‘Defensive’ pharma scales new peak as Street looks beyond high-growth plays

August 28, 2024

Pharma stocks have gained investor interest as the Nifty Pharma index reaches new highs. Amid economic uncertainties, defensive sectors like pharma offer minimal risk. Notable picks include Lupin, Sun Pharma, and Dr Reddy’s. The sector saw significant foreign inflows, driven by the performance of the generic drug Revlimid.

More To Explore

Pak conflict: Indian QSR stock with Turkey ops in crossfire amid boycott calls

Jubilant FoodWorks may face business pressure due to rising India-Turkey tensions following Türkiye’s support for Pakistan. Its Domino’s Turkey unit, DP Eurasia, contributes significantly to

May 14, 2025

Sebi comes out with composition of internal audit team for CRAs

Markets regulator Sebi on Wednesday expanded the list of eligible professionals who can be part of the internal audit team for Credit Rating Agencies (CRAs),

May 14, 2025

Advertiser Disclosure

Great-investor.com helps users across the globe to find out The latest news, Guides, and Info about finance and investments. Furthermore, our content and research teams do not participate in any advertising planning nor are they permitted access to advertising campaign data.

Disclaimer

It is our organization’s primary mission to provide reviews, commentary, and analysis that are unbiased and objective. While great-investor.com has some data verified by industry participants, it can vary from time to time. Operating as an online business, this site may be compensated through third party advertisers. Our receipt of such compensation shall not be construed as an endorsement or recommendation by great-investor.com, nor shall it bias our reviews, analysis, and opinions. Please see our General Disclaimers for more information

Top10 International FZ LLE | 17th Floor, Creative Tower | 4422 | Fujairah | TRN: 100608946800003